News & Entertainment

Coronavirus India Live Updates: Ahmedabad extends night curfew until further orders

Coronavirus (Covid-19) India Live News Updates: With 402 new fatalities, the country’s death toll mounted to 140,590.

Updated: December 7, 2020 | 3:23:53 pm

Coronavirus India Live Updates: The night curfew in Ahmedabad was extended on Monday a day after the city reported over 300 new cases, the highest in Gujarat. The night curfew that came into effect on November 23 and was extended till December 7 earlier. This time it has been extended until further notice. “There will be a curfew between 9 pm and 6 am beginning December 7 until further order in this regard,” city order announced. A similar night curfew has also been enforced in Rajkot, Vadodara and Surat since November 21.

India detected 32,272 new Covid-19 cases in the 24 hours ending 8 am Monday, taking the country’s overall tally to over 96.77 lakh. Out of the total cases, active cases further dropped to 3.96 lakh, a level last seen in the third week of July. Over 91.39 lakh people have recovered with over 39,000 recoveries in the last 24 hours. With 391 new fatalities, the country’s death toll mounted to 1,40,590. The number of single-day fatalities has fallen below 400 for the first time since July.

The Serum Institute of India Sunday became the first indigenous company to seek emergency use authorization for its Oxford Covid-19 vaccine candidate, Covishield. The Pune-based institute in collaboration with ICMR is conducting its phase-3 trials of the Oxford-AstraZeneca candidate. This comes a day after US pharmaceutical giant, Pfizer asked for emergency use of its vaccine candidate.

The Drug Controller General of India (DCGI) has placed Pfizer’s request before a committee of experts to examine the date of its clinical trial conducted overseas, The Indian Express has learnt.

As states prepare for the distribution and allocation of a possible Covid-19 vaccine, Chief Minister Amarinder Singh Sunday urged Prime Minister Narendra Modi to ensure priority allocation of COVID-19 vaccine to Punjab on account of its higher mortality rate and high levels of co-morbidities in the state.

Show More

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button